BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27363654)

  • 1. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.
    Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L
    J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma.
    Sulpice L; Rayar M; Turlin B; Boucher E; Bellaud P; Desille M; Meunier B; Clément B; Boudjema K; Coulouarn C
    J Surg Res; 2014 Nov; 192(1):117-23. PubMed ID: 24909871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
    Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
    World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma.
    Xu J; Li D; Li X; Liu Z; Li T; Jiang P; He Q; Tian F; Gao Y; Wang D; Wang S
    Dig Liver Dis; 2014 Aug; 46(8):750-7. PubMed ID: 24794791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.
    Abe T; Amano H; Shimamoto F; Hattori M; Kuroda S; Kobayashi T; Tashiro H; Ohdan H
    Eur J Surg Oncol; 2015 Nov; 41(11):1515-21. PubMed ID: 26210654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma.
    Sarcognato S; Gringeri E; Fassan M; Di Giunta M; Maffeis V; Guzzardo V; Cillo U; Guido M
    Virchows Arch; 2019 Jan; 474(1):29-37. PubMed ID: 30377796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
    Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
    Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancer of zeste homolog 2 (EZH2) promotes progression of cholangiocarcinoma cells by regulating cell cycle and apoptosis.
    Nakagawa S; Okabe H; Sakamoto Y; Hayashi H; Hashimoto D; Yokoyama N; Sakamoto K; Kuroki H; Mima K; Nitta H; Imai K; Chikamoto A; Watanabe M; Beppu T; Baba H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S667-75. PubMed ID: 23887863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
    Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J
    Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of downregulation of WWOX with poor prognosis in patients with intrahepatic cholangiocarcinoma after curative resection.
    Huang C; Tian Y; Peng R; Zhang C; Wang D; Han S; Jiao C; Wang X; Zhang H; Wang Y; Li X
    J Gastroenterol Hepatol; 2015 Feb; 30(2):421-33. PubMed ID: 25168293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.
    Gu S; Chen J; Zhou Q; Yan M; He J; Han X; Qiu Y
    Dig Dis Sci; 2020 Feb; 65(2):500-508. PubMed ID: 31489563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
    Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications.
    Zhang C; Liu LX; Dong ZR; Shi GM; Cai JB; Zhang PF; Ke AW; Yu JX; Zhou J; Fan J
    Tumour Biol; 2015 Mar; 36(3):1781-9. PubMed ID: 25391422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of LOXL2 with GATA6 induces VEGFA expression and angiogenesis in cholangiocarcinoma.
    Peng T; Deng X; Tian F; Li Z; Jiang P; Zhao X; Chen G; Chen Y; Zheng P; Li D; Wang S
    Int J Oncol; 2019 Sep; 55(3):657-670. PubMed ID: 31322171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma.
    Talabnin C; Janthavon P; Thongsom S; Suginta W; Talabnin K; Wongkham S
    Hum Pathol; 2016 Jun; 52():47-54. PubMed ID: 26980022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis.
    Choi J; Chung T; Rhee H; Kim YJ; Jeon Y; Yoo JE; Noh S; Han DH; Park YN
    Gut Liver; 2019 Jan; 13(1):83-92. PubMed ID: 29938458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome.
    Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F
    Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.